Form Type: 4

SEC EDGAR Link
Accession Number:0001735276-19-000122
Date:2019-12-23
Issuer: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Original Submission Date:

Reporting Person:

MARAGANORE JOHN
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
PERFORMANCE STOCK OPTION 2017 (RIGHT TO BUY) 119.13 2019-12-23 deemed execution date A 17,498 (a) 2019-12-23 2028-03-01 common stock 17,498 $119.13 34,996 direct
Footnotes
IDfootnote
f1 on march 1, 2018, the reporting person was granted a performance based stock option to purchase shares of alny common stock. one third of the shares subject to the option vest upon the achievement of each of three specific clinical development, regulatory or commercial events, as approved by our compensation committee. the compensation committee of the company determined that the second performance criterion was met and the option vested as to the second one third of the shares as of december 23, 2019.
WhaleWisdom Logo

Elevate your investments